Thompson CM , Sonawane B, Barton HA, DeWoskin RS, Schlosser P, Lipscomb JC, Chiu W, Krishnan K. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health B 11(7):519–547; doi: 10.1080/10937400701724337 .
View Abstract
Publication: Manuscripts modeling , PBPK , pharmacokinetics , risk assessment
Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.
Publication: Abstracts and Presentations arsenic
Robison TW . Case examples of qualification of extractables and leachables in therapeutic biologic products: A toxicological perspective. WCBP CMC Strategy Forum–Extractables and Leachables: Challenges and Strategies in Biopharmaceutical Development (Sponsored by CASSS and the United States Food and Drug Administration), Washington, DC, January 2008.
Publication: Abstracts and Presentations leachables
DeSesso JM, Watson RE, Keen CL, Hazelden KP, Haws LC , Li AA. 2008. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: A case study of dimethoate. J Toxicol Environ Health A 72(2):94-109; doi: 10.1080/15287390802477452 .
View Abstract
Publication: Manuscripts dimethoate , Exposure Assessment , Toxicology
Hinerman J , Mueser T. Protein-protein interactions between bacteriophage T4 helicase assembly protein and single-stranded DNA binding protein. Poster presented to Ohio Crystallographic Symposium Meeting, University of Toledo, Toledo, OH, fall 2007.
